Diagnostic Innovations in Glaucoma Study (DIGS)
This observational study, called the Diagnostic Innovations in Glaucoma Study (DIGS), aims to better understand how glaucoma (increased pressure inside the eye that can cause vision loss) affects vision and the structure of the back of the eye. Researchers are looking for the best ways to detect glaucoma and track its progression, especially in people with or without myopia (nearsightedness). They also want to see how glaucoma impacts daily life and quality of life. The study is open to adults aged 18 and older, including healthy individuals, those at risk for glaucoma, and those already diagnosed with glaucoma, with or without myopia. The goal is to improve how we manage glaucoma.
- Study design
- This is an observational study with a planned enrollment of 3000 participants. It is a longitudinal study, meaning participants are followed over time.
- What's involved
- Participants with or without myopia are typically examined about twice a year. Healthy controls with or without myopia are usually examined once.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Diagnostic Innovations in Glaucoma Study
At a glance
A primary outcome measure isn't published for this study.
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Linda Zangwill, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Diego
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.